AU7481391A - Engrafting allogeneic tissues or organs using interleukin - Google Patents

Engrafting allogeneic tissues or organs using interleukin

Info

Publication number
AU7481391A
AU7481391A AU74813/91A AU7481391A AU7481391A AU 7481391 A AU7481391 A AU 7481391A AU 74813/91 A AU74813/91 A AU 74813/91A AU 7481391 A AU7481391 A AU 7481391A AU 7481391 A AU7481391 A AU 7481391A
Authority
AU
Australia
Prior art keywords
engrafting
interleukin
organs
allogeneic tissues
allogeneic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU74813/91A
Inventor
David H Sachs
Megan Sykes
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
US Department of Commerce
Original Assignee
US Department of Health and Human Services
US Government
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by US Department of Health and Human Services, US Government filed Critical US Department of Health and Human Services
Publication of AU7481391A publication Critical patent/AU7481391A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2013—IL-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
AU74813/91A 1990-02-27 1991-02-27 Engrafting allogeneic tissues or organs using interleukin Abandoned AU7481391A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US48587990A 1990-02-27 1990-02-27
US485879 1990-02-27

Publications (1)

Publication Number Publication Date
AU7481391A true AU7481391A (en) 1991-09-18

Family

ID=23929794

Family Applications (1)

Application Number Title Priority Date Filing Date
AU74813/91A Abandoned AU7481391A (en) 1990-02-27 1991-02-27 Engrafting allogeneic tissues or organs using interleukin

Country Status (2)

Country Link
AU (1) AU7481391A (en)
WO (1) WO1991012849A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2683226B1 (en) * 1991-10-30 1995-06-09 Univ Paris Curie CELLS TRAPED AGAINST ANTIGENS CAUSING DYSFUNCTION OF THE IMMUNE SYSTEM, MEDICINES FOR THE PREVENTION OR TREATMENT OF DISEASES INDUCED BY SUCH DYSFUNCTIONS.
WO1996037208A1 (en) * 1995-05-25 1996-11-28 Baxter International Inc. Allogeneic cell therapy for cancer following allogeneic stem cell transplantation

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4388309A (en) * 1981-06-10 1983-06-14 Shanksville Corporation, N.V. Process for suppressing graft rejection in organ transplantation
US4489710A (en) * 1981-06-23 1984-12-25 Xoma Corporation Composition and method for transplantation therapy
US4778879A (en) * 1982-04-20 1988-10-18 Sloan-Kettering Institute For Cancer Research Highly purified human interleukin 2 and method
US4863727A (en) * 1986-04-09 1989-09-05 Cetus Corporation Combination therapy using interleukin-2 and tumor necrosis factor
US4808611A (en) * 1986-07-30 1989-02-28 Immunex Corporation Use of interleukin-1 to induce development of multipotent hemopoietic cell populations

Also Published As

Publication number Publication date
WO1991012849A1 (en) 1991-09-05

Similar Documents

Publication Publication Date Title
AU6997291A (en) Skin care compositions
AU2049788A (en) Skin care compositions
AU7122291A (en) 3-arylcarbonyl-1h-indoles useful as therapeutic agents
ZA915644B (en) Gel formulations
EP0466552A3 (en) Biomedical adhesive compositions
AU8554691A (en) Improved formulations
AU7406491A (en) Endoscopic aspiraton instrument
AU1305588A (en) Skin care compositions
IL98803A0 (en) Gel formulations
AU7599987A (en) Microbicidal disinfectant composition
AU5020490A (en) Chorion biopsy catheter
AU7453391A (en) Genetically engineered human lactoferrin
EP0443854A3 (en) Endoscope
GB2243297B (en) Insecticidal compositions
AU7928191A (en) Compositions
AU6991891A (en) Herbicidal compositions
AU5113690A (en) Microbicidal compositions
AU8905691A (en) Selenomerocyanine photosensitizers
AU7481391A (en) Engrafting allogeneic tissues or organs using interleukin
AU1769488A (en) Disinfectant compositions
IL97366A (en) Aryl-propyl-amines their preparation and their use as fungicides
AU8372591A (en) Forage composition
AU634752B2 (en) Microbicidal compositions
GB9023698D0 (en) Polymerisable compositions
AU7379391A (en) Non surgical mulesing